• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 I 型猫冠状病毒病毒样颗粒疫苗的制备及其在小鼠和猫中的免疫原性。

Preparation of a novel type I feline coronavirus virus-like particle vaccine and its immunogenicity in mice and cats.

机构信息

College of Animal and Veterinary Sciences, Southwest Minzu University, Chengdu, 610041, China.

College of Animal and Veterinary Sciences, Southwest Minzu University, Chengdu, 610041, China; Key laboratory of Ministry of Education and Sichuan Province for Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Chengdu, 610041, China.

出版信息

Microb Pathog. 2024 Sep;194:106795. doi: 10.1016/j.micpath.2024.106795. Epub 2024 Jul 15.

DOI:10.1016/j.micpath.2024.106795
PMID:39019122
Abstract

Feline coronavirus (FCoV) infection is a leading cause of death in cats. In this study, we produced FCoV-I virus-like particles (VLPs) containing E, M, N, and S proteins using a baculovirus expression system and mixed VLPs with the adjuvants MF59 and CpG 55.2 to prepare an VLP/MF59/CpG vaccine. After immunization of mice with the vaccine, IgG specific antibodies titers against S and N proteins increased to 1:12,800, and IFN-γ and IL-4 splenocytes were significantly increased. Following immunization of FCoV-negative cats, the S protein antibodies in immunized cats (5/5) increased significantly, with a peak of 1:12,800. Notably, after booster vaccination in FCoV-positive cats, a significant reduction in viral load was observed in the feces of partial cats (4/5), and the FCoV-I negative conversion was found in two immunized cats (2/5). Therefore, the VLP/MF59/CpG vaccine is a promising candidate vaccine to prevent the FCoV infection.

摘要

猫冠状病毒(FCoV)感染是导致猫死亡的主要原因之一。在这项研究中,我们使用杆状病毒表达系统生产了含有 E、M、N 和 S 蛋白的 FCoV-I 病毒样颗粒(VLPs),并将 VLPs 与佐剂 MF59 和 CpG 55.2 混合,制备了 VLP/MF59/CpG 疫苗。用该疫苗对小鼠进行免疫后,针对 S 和 N 蛋白的 IgG 特异性抗体滴度增加到 1:12800,IFN-γ 和 IL-4 脾细胞明显增加。对 FCoV 阴性猫进行免疫后,免疫猫(5/5)的 S 蛋白抗体显著增加,峰值为 1:12800。值得注意的是,在 FCoV 阳性猫中进行加强免疫后,部分猫(4/5)粪便中的病毒载量显著降低,并且在 2 只免疫猫(2/5)中发现了 FCoV-I 阴性转换。因此,VLP/MF59/CpG 疫苗是预防 FCoV 感染的一种有前途的候选疫苗。

相似文献

1
Preparation of a novel type I feline coronavirus virus-like particle vaccine and its immunogenicity in mice and cats.新型 I 型猫冠状病毒病毒样颗粒疫苗的制备及其在小鼠和猫中的免疫原性。
Microb Pathog. 2024 Sep;194:106795. doi: 10.1016/j.micpath.2024.106795. Epub 2024 Jul 15.
2
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.在非人灵长类动物中,一种新型冠状病毒重组植物源性病毒样颗粒候选疫苗的无佐剂和佐剂制剂的安全性、免疫原性和保护作用。
Cell Mol Immunol. 2022 Feb;19(2):222-233. doi: 10.1038/s41423-021-00809-2. Epub 2022 Jan 5.
3
Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam.重组杆状病毒BacMam表达的SARS-CoV-2病毒样颗粒的构建及免疫原性
Microbiol Spectr. 2024 Aug 6;12(8):e0095924. doi: 10.1128/spectrum.00959-24. Epub 2024 Jun 25.
4
Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.一种新型中东呼吸综合征冠状病毒嵌合病毒样颗粒候选疫苗在小鼠体内诱导产生显著的刺突蛋白特异性IgG和中和抗体
Virol Sin. 2018 Oct;33(5):453-455. doi: 10.1007/s12250-018-0064-8. Epub 2018 Oct 29.
5
Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats.重组猫冠状病毒作为疫苗候选物可在 SPF 猫中提供保护,但不能在常规猫中提供保护。
Vet Microbiol. 2014 Mar 14;169(3-4):154-62. doi: 10.1016/j.vetmic.2013.10.015. Epub 2013 Oct 29.
6
Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins.携带传染性支气管炎病毒 M 和 S 蛋白的冠状病毒样颗粒的组装和免疫原性。
Vaccine. 2013 Nov 12;31(47):5524-30. doi: 10.1016/j.vaccine.2013.09.024. Epub 2013 Oct 5.
7
An eight-year epidemiologic study based on baculovirus-expressed type-specific spike proteins for the differentiation of type I and II feline coronavirus infections.一项基于杆状病毒表达的型特异性刺突蛋白的八年流行病学研究,用于区分I型和II型猫冠状病毒感染。
BMC Vet Res. 2014 Aug 15;10:186. doi: 10.1186/s12917-014-0186-7.
8
A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses.一种由重组杆状病毒系统生产的嵌合苏丹病毒样颗粒疫苗候选物在小鼠和马中诱导特异性免疫应答。
Viruses. 2020 Jan 3;12(1):64. doi: 10.3390/v12010064.
9
Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats.猫乳头瘤病毒2型病毒样颗粒疫苗对成年猫安全且具有免疫原性,但不能降低猫乳头瘤病毒2型(FcaPV-2)的病毒载量。
Vet Immunol Immunopathol. 2019 Jul;213:109888. doi: 10.1016/j.vetimm.2019.109888. Epub 2019 Jun 28.
10
Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.金纳米颗粒佐剂 S 蛋白诱导针对严重急性呼吸综合征相关冠状病毒感染的强烈抗原特异性 IgG 反应,但不能诱导保护性抗体并限制肺部嗜酸性粒细胞浸润。
Microbiol Immunol. 2020 Jan;64(1):33-51. doi: 10.1111/1348-0421.12754. Epub 2019 Nov 18.